title: Need for more intensive treatment of patients with acute pulmonary embolism caused by heparin-induced thrombocytopaenia Type II.
authors.forename: Nebojsa M
authors.initials: NM
authors.lastname: Antonijevic
authors.forename: Rajko
authors.initials: R
authors.lastname: Milosevic
authors.forename: Jovan
authors.initials: J
authors.lastname: Perunicic
authors.forename: Milica
authors.initials: M
authors.lastname: Stanojevic
authors.forename: Branko
authors.initials: B
authors.lastname: Calija
authors.forename: Zorana
authors.initials: Z
authors.lastname: Vasiljevic
mesh_terms: D000925:Anticoagulants / Q000009:adverse effects*; D006495:Heparin, Low-Molecular-Weight / Q000009:adverse effects*; D006801:Humans; D011655:Pulmonary Embolism / Q000139:chemically induced*; D012307:Risk Factors; D013921:Thrombocytopenia / Q000139:chemically induced*
chemical_list: D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight